Lazard Asset Management »

Haemonetics Corporation shares owned by Lazard Asset Management

Quarter-by-quarter ownership of Haemonetics Corporation (HAE) shares owned by Lazard Asset Management from 13F filings

Historical chart of Lazard Asset Management investment in Haemonetics Corporation

Tip: Access up to 7 years of quarterly data

All positions including Haemonetics Corporation held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Haemonetics Corporation by Lazard Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.2M 16k 79.06
2024-06-30 $692k 8.5k 81.83
2024-03-31 $884k 10k 85.29
2023-12-31 $3.1M 37k 85.49
2023-09-30 $3.5M 39k 89.57
2023-06-30 $1.5M 18k 85.11
2023-03-31 $3.6M 43k 82.73
2022-12-31 $3.3M 42k 78.64
2022-09-30 $3.3M 44k 74.03
2021-12-31 $2.2M 42k 53.02
2021-09-30 $3.0k 47 63.83
2021-06-30 $3.0k 47 63.83
2021-03-31 $3.7M 34k 110.98
2020-12-31 $50k 423 118.20
2020-09-30 $36k 423 85.11
2020-06-30 $21k 236 88.98
2020-03-31 $70k 706 99.15
2018-12-31 $261k 3.7k 71.43
2018-09-30 $65k 572 113.64
2018-06-30 $394k 4.4k 89.67
2018-03-31 $548k 7.5k 73.13
2017-12-31 $274k 4.7k 58.04
2013-12-31 $8.1M 191k 42.13
2013-09-30 $9.9M 247k 39.88
2013-06-30 $10M 244k 41.35
2012-12-31 $14M 333k 40.84